April 28, 2000
Patent on a Painkiller Could Be Worth Billions to the U. of Rochester
A drug patent awarded to the University of Rochester for a new class of painkillers could generate billions of dollars in royalties for the institution, potentially becoming the most lucrative patent held by a university, officials there have announced.
The patent covers drugs known as Cox-2 inhibitors, or superaspirin. A team of Rochester researchers discovered the chemical mechanisms that made development of the drugs possible.
Within hours of
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review

-
Government

-
Advice



